Johnson & Johnson [NYSE: JNJ] traded at a low on 03/17/23, posting a -1.07 loss after which it closed the day’ session at $152.38. The company report on March 15, 2023 that Johnson & Johnson to Host Investor Conference Call on First-Quarter Results.
Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 18th to review first-quarter results. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include additional members of Johnson & Johnson’s executive team.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Investors and other interested parties can access the webcast/conference call in the following ways:.
The results of the trading session contributed to over 20293307 shares changing hands. Over the past one week, the price volatility of Johnson & Johnson stands at 1.74% while the volatility over the past one month is 1.43%.
The market cap for JNJ stock reached $401.14 billion, with 2.61 billion shares outstanding and 2.09 billion shares in the current float. Compared to the average trading volume of 7.64M shares, JNJ reached a trading volume of 20293307 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Johnson & Johnson [JNJ]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JNJ shares is $181.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JNJ stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Johnson & Johnson shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 01, 2023. While these analysts kept the previous recommendation, Credit Suisse raised their target price to Neutral. The new note on the price target was released on November 18, 2022, representing the official price target for Johnson & Johnson stock. Previously, the target price had yet another raise to $175, while Barclays analysts kept a Equal Weight rating on JNJ stock. On October 14, 2022, analysts decreased their price target for JNJ shares from 185 to 178.
The Average True Range (ATR) for Johnson & Johnson is set at 2.39, with the Price to Sales ratio for JNJ stock in the period of the last 12 months amounting to 4.23. The Price to Book ratio for the last quarter was 5.19, with the Price to Cash per share for the same quarter was set at 8.93. Price to Free Cash Flow for JNJ in the course of the last twelve months was 72.89 with Quick ratio for the last quarter at 0.80.
How has JNJ stock performed recently?
Johnson & Johnson [JNJ] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.51. With this latest performance, JNJ shares dropped by -4.39% in over the last four-week period, additionally sinking by -7.69% over the last 6 months – not to mention a drop of -12.69% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for JNJ stock in for the last two-week period is set at 35.10, with the RSI for the last a single of trading hit 36.75, and the three-weeks RSI is set at 34.66 for Johnson & Johnson [JNJ]. The present Moving Average for the last 50 days of trading for this stock 162.47, while it was recorded at 153.55 for the last single week of trading, and 169.36 for the last 200 days.
Johnson & Johnson [JNJ]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Johnson & Johnson [JNJ] shares currently have an operating margin of +26.08 and a Gross Margin at +67.67. Johnson & Johnson’s Net Margin is presently recorded at +18.88.
Return on Equity for this stock inclined to 23.79, with Return on Assets sitting at 9.71.
Johnson & Johnson’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.80 and a Current Ratio set at 1.00.
Earnings analysis for Johnson & Johnson [JNJ]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JNJ. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Johnson & Johnson go to 3.94%.
Insider trade positions for Johnson & Johnson [JNJ]
There are presently around $280,726 million, or 70.80% of JNJ stock, in the hands of institutional investors. The top three institutional holders of JNJ stocks are: VANGUARD GROUP INC with ownership of 246,826,621, which is approximately 0.606% of the company’s market cap and around 0.08% of the total institutional ownership; BLACKROCK INC., holding 198,802,769 shares of the stock with an approximate value of $30.29 billion in JNJ stocks shares; and STATE STREET CORP, currently with $21.65 billion in JNJ stock with ownership of nearly 0.14% of the company’s market capitalization.
Positions in Johnson & Johnson stocks held by institutional investors increased at the end of Tuesday and at the time of the Tuesday reporting period, where 1,894 institutional holders increased their position in Johnson & Johnson [NYSE:JNJ] by around 63,671,240 shares. Additionally, 1,621 investors decreased positions by around 42,152,083 shares, while 376 investors held positions by with 1,736,452,752 shares. The mentioned changes placed institutional holdings at 1,842,276,075 shares, according to the latest SEC report filing. JNJ stock had 273 new institutional investments in for a total of 11,384,032 shares, while 88 institutional investors sold positions of 2,706,634 shares during the same period.